GABA system dysfunction in autism and related disorders: from synapse to symptoms
about
Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models.New Therapeutic Options for Autism Spectrum Disorder: Experimental EvidencesGABAergic signaling as therapeutic target for autism spectrum disordersDecreased left perisylvian GABA concentration in children with autism and unaffected siblingsComplementary and Alternative Therapies for Autism Spectrum DisorderProspective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disordersAn evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autismInfluence of maternal thyroid hormones during gestation on fetal brain development.Primary Cilia as a Possible Link between Left-Right Asymmetry and Neurodevelopmental Diseases.GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.Neurophysiological hyperresponsivity to sensory input in autism spectrum disorders.Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice.Enhanced olfactory sensitivity in autism spectrum conditionsGestational and early postnatal hypothyroidism alters VGluT1 and VGAT bouton distribution in the neocortex and hippocampus, and behavior in rats.Test-retest reliability of the 40 Hz EEG auditory steady-state response.Atypical excitation-inhibition balance in autism captured by the gamma response to contextual modulation.Autistic traits and abnormal sensory experiences in adults.Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.Modulation of corticospinal excitability by transcranial magnetic stimulation in children and adolescents with autism spectrum disorder.Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.Anterior insula GABA levels correlate with emotional aspects of empathy: a proton magnetic resonance spectroscopy study.The treatment of autism with low-dose phenytoin: a case report."Brain MR spectroscopy in autism spectrum disorder-the GABA excitatory/inhibitory imbalance theory revisited"Fmr1 KO and fenobam treatment differentially impact distinct synapse populations of mouse neocortex.Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information?Double Dissociation of the Roles of Metabotropic Glutamate Receptor 5 and Oxytocin Receptor in Discrete Social Behaviors.Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophreniaDecreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA).Selective Dysregulation of Hippocampal Inhibition in the Mouse Lacking Autism Candidate Gene CNTNAP2.Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autismNeuroligin-2 and the tightrope of excitation/inhibition balance in the prefrontal cortexIncreased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS studyThe basolateral amygdala γ-aminobutyric acidergic system in health and disease.Resting State Functional Connectivity MRI among Spectral MEG Current Sources in Children on the Autism Spectrum.Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.Brief Report: The Go/No-Go Task Online: Inhibitory Control Deficits in Autism in a Large Sample.Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study.
P2860
Q21129461-F516865C-598F-4CED-88F0-43BADB58BCD6Q26771762-25E2F61D-0E06-4C39-BE3B-00BDE79B0F77Q27013583-400E146B-A884-4E8D-811F-5262B08F93A9Q27013590-81A97339-4C4E-49F4-895F-174E8488F252Q28082433-365500A3-0560-43F2-A973-99D90F1EEA23Q28083480-9C1F5763-415B-4373-B9B9-F970B1D41FC9Q28086869-3E171B50-F23B-493C-AC4D-724CEFDB974DQ28655923-6E78E8F5-B636-4EC9-9668-52E431CE6150Q30252084-9C389B53-8C95-4D7C-B2B6-38CEDEED5220Q30361244-9A2F7BDD-0ECA-4E58-84D4-D04389BF30AFQ30363617-2394A9D1-D408-4EFB-9238-FA6EC611A190Q30376849-2D53DFB5-AE85-446A-BF80-AAF3312B06C7Q30395471-7444A400-EA58-41A3-809A-5F759D926B37Q30413649-6BD2D9B4-2175-4B3A-AEDB-DA923D5ADD48Q30417259-F1C06D56-7360-4FEB-AF5A-F79A66497C50Q30444094-E14E9B9D-D3C3-4866-83F7-C0CA3E2F9884Q30548456-83136353-057A-4E25-BAD8-671F5B071D89Q33619935-844E394C-C5A6-40D4-B0D7-9F68D3694207Q33659830-15F401FB-7C4A-456D-97E3-48887FF4523DQ34004330-1A5D286B-7526-41A2-895E-6CCBDDFB8D91Q34038438-4DC5A115-E6ED-4AC5-87DC-9B15F16EBBF9Q34044050-E8DFD438-F0C4-4452-B09D-2A4A5196321BQ34392818-3F384FE3-BF43-4B41-AC4F-DA5C6065BCA2Q34566476-E77FEC5B-6837-460C-92D2-87EA0D81AC4CQ35530114-BD0AF2F2-B095-4AAE-B5D0-4EA414681E90Q35764150-DC8693EE-B862-462E-928C-AE2054004ACDQ35776690-60EC6F88-446C-447F-A405-26FAA0EAA59AQ35824354-67B74021-3556-4332-B89E-1D4C6F9CB30FQ35960336-9637CA04-FA9B-45D0-82B6-478C07C527BBQ36145999-6489A304-CAD2-41E6-9352-E6BE4958AB5CQ36165457-24741BDD-6AD1-4558-89F8-413B6A2665FCQ36215384-C1E34B8B-C399-4EA0-A51F-B79F54473289Q36508743-E780E767-1DD6-4859-8F86-58E66157463AQ36598019-A036EE6C-99CA-4799-8063-32E95450989DQ36632136-419AB3F3-7253-431B-BA46-F6942FE9F751Q36813950-7F7E252C-FFCF-4B04-810A-46F95D37CA37Q36985207-B75A40C9-D041-431C-820A-2F4B2993B4F8Q37065273-2DD5738C-BEDA-4B11-ABE6-5B458D5B22B6Q37079983-1909F9CB-3409-4234-961D-D6747D215811Q37155073-7C324136-0198-4B2F-818E-3B96D8F07AFA
P2860
GABA system dysfunction in autism and related disorders: from synapse to symptoms
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@ast
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@en
type
label
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@ast
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@en
prefLabel
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@ast
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@en
P2860
P50
P1476
GABA system dysfunction in autism and related disorders: from synapse to symptoms
@en
P2093
M Andreina Mendez
Suzanne Coghlan
P2860
P304
P356
10.1016/J.NEUBIOREV.2012.07.005
P577
2012-07-25T00:00:00Z